202 related articles for article (PubMed ID: 21742301)
21. [Treatment of keratoacanthoma with intralesional methotrexate injections].
Richard MA; Gachon J; Choux R; Laurans R; Folchetti G; Grob JJ
Ann Dermatol Venereol; 2000 Dec; 127(12):1097. PubMed ID: 11173689
[No Abstract] [Full Text] [Related]
22. Intralesional methotrexate for keratoacanthoma of the nose.
Cohen PR; Schulze KE; Teller CF; Nelson BR
Skinmed; 2005; 4(6):393-5. PubMed ID: 16276163
[TBL] [Abstract][Full Text] [Related]
23. Topical and intralesional treatment of nonmelanoma skin cancer: efficacy and cost comparisons.
Chitwood K; Etzkorn J; Cohen G
Dermatol Surg; 2013 Sep; 39(9):1306-16. PubMed ID: 23915332
[TBL] [Abstract][Full Text] [Related]
24. Neoadjuvant chemotherapy in squamous cell carcinoma of the esophagus using low dose continuous infusion 5-fluorouracil and cisplatin: results of a prospective study.
Aroori S; Parshad R; Kapoor A; Gupta SD; Kumar A; Chattophadyay TK
Indian J Cancer; 2004; 41(1):3-7. PubMed ID: 15105572
[TBL] [Abstract][Full Text] [Related]
25. Osteogenic sarcoma of the extremity with detectable lung metastases at presentation. Results of treatment of 23 patients with chemotherapy followed by simultaneous resection of primary and metastatic lesions.
Bacci G; Mercuri M; Briccoli A; Ferrari S; Bertoni F; Donati D; Monti C; Zanoni A; Forni C; Manfrini M
Cancer; 1997 Jan; 79(2):245-54. PubMed ID: 9010097
[TBL] [Abstract][Full Text] [Related]
26. Multiple keratoacanthomas occurring in surgical margins and de novo treated with intralesional methotrexate.
Veerula VL; Ezra N; Aouthmany M; Graham TA; Wolverton SE; Somani AK
Cutis; 2016 Dec; 98(6):E12-E15. PubMed ID: 28099546
[TBL] [Abstract][Full Text] [Related]
27. Neoadjuvant chemotherapy in stage IB2 squamous cell carcinoma of the cervix.
Serur E; Mathews RP; Gates J; Levine P; Maiman M; Remy JC
Gynecol Oncol; 1997 May; 65(2):348-56. PubMed ID: 9159350
[TBL] [Abstract][Full Text] [Related]
28. Intralesional therapy for the treatment of keratoacanthoma.
Kiss N; Avci P; Bánvölgyi A; Lőrincz K; Szakonyi J; Gyöngyösi N; Fésűs L; Lee G; Wikonkál N
Dermatol Ther; 2019 May; 32(3):e12872. PubMed ID: 30866135
[TBL] [Abstract][Full Text] [Related]
29. Comparison of topical methyl aminolevulinate photodynamic therapy with cryotherapy or Fluorouracil for treatment of squamous cell carcinoma in situ: Results of a multicenter randomized trial.
Morton C; Horn M; Leman J; Tack B; Bedane C; Tjioe M; Ibbotson S; Khemis A; Wolf P
Arch Dermatol; 2006 Jun; 142(6):729-35. PubMed ID: 16785375
[TBL] [Abstract][Full Text] [Related]
30. A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors.
Glantz MJ; Jaeckle KA; Chamberlain MC; Phuphanich S; Recht L; Swinnen LJ; Maria B; LaFollette S; Schumann GB; Cole BF; Howell SB
Clin Cancer Res; 1999 Nov; 5(11):3394-402. PubMed ID: 10589750
[TBL] [Abstract][Full Text] [Related]
31. [Topical and systemic chemotherapy with 5-fluouracil in facial carcinoma secondary to xeroderma pigmentosum].
Khader A; Gritli S; Boussen I; Oueslati Z; Ferjaoui M; Nouira R; Ladgham A; Boussen H
Tunis Med; 2005 Nov; 83(11):672-4. PubMed ID: 16422364
[TBL] [Abstract][Full Text] [Related]
32. Intralesional and intravenous treatment of cutaneous B-cell lymphomas with the monoclonal anti-CD20 antibody rituximab: report and follow-up of eight cases.
Kerl K; Prins C; Saurat JH; French LE
Br J Dermatol; 2006 Dec; 155(6):1197-200. PubMed ID: 17107389
[TBL] [Abstract][Full Text] [Related]
33. Continuous intraarterial infusion chemotherapy for early lip cancer.
Wu CF; Chen CM; Chen CH; Shieh TY; Sheen MC
Oral Oncol; 2007 Sep; 43(8):825-30. PubMed ID: 17207655
[TBL] [Abstract][Full Text] [Related]
34. Dose escalation of parenteral methotrexate in active rheumatoid arthritis that has been unresponsive to conventional doses of methotrexate: a randomized, controlled trial.
Lambert CM; Sandhu S; Lochhead A; Hurst NP; McRorie E; Dhillon V
Arthritis Rheum; 2004 Feb; 50(2):364-71. PubMed ID: 14872477
[TBL] [Abstract][Full Text] [Related]
35. Eruptive squamous atypia (also known as eruptive keratoacanthoma): Definition of the disease entity and successful management via intralesional 5-fluorouracil.
Que SKT; Compton LA; Schmults CD
J Am Acad Dermatol; 2019 Jul; 81(1):111-122. PubMed ID: 31103317
[TBL] [Abstract][Full Text] [Related]
36. Subset of patients with verrucous carcinoma of the oral cavity who benefit from treatment with methotrexate.
Karagozoglu KH; Buter J; Leemans CR; Rietveld DH; van den Vijfeijken S; van der Waal I
Br J Oral Maxillofac Surg; 2012 Sep; 50(6):513-8. PubMed ID: 22000636
[TBL] [Abstract][Full Text] [Related]
37. Keratoacanthoma as a postoperative complication of skin cancer excision.
Goldberg LH; Silapunt S; Beyrau KK; Peterson SR; Friedman PM; Alam M
J Am Acad Dermatol; 2004 May; 50(5):753-8. PubMed ID: 15097960
[TBL] [Abstract][Full Text] [Related]
38. Methotrexate infusion and folinic acid as primary therapy for nonmetastatic and low-risk metastatic gestational trophoblastic tumors. 15 years of experience.
Garrett AP; Garner EO; Goldstein DP; Berkowitz RS
J Reprod Med; 2002 May; 47(5):355-62. PubMed ID: 12063874
[TBL] [Abstract][Full Text] [Related]
39. Keratoacanthoma observed.
Griffiths RW
Br J Plast Surg; 2004 Sep; 57(6):485-501. PubMed ID: 15308394
[TBL] [Abstract][Full Text] [Related]
40. Photofrin-mediated photodynamic therapy for treatment of aggressive head and neck nonmelanomatous skin tumors in elderly patients.
Gayl Schweitzer V
Laryngoscope; 2001 Jun; 111(6):1091-8. PubMed ID: 11404627
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]